Efficacy and Safety of Neoadjuvant GEMOX Chemotherapy Combined with Lenvatinib and Tislelizumab in Patients with Resectable Biliary Tract Malignancies at High Risk of Recurrence

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 862667bdff152f14ccd45561884c508424e7d753
First added on: Oct 10, 2026